Concourse Financial Group Securities, Inc. Drug Manufacturers—Specialty & Generic

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ZTS Zoetis Inc.	$78.3B	$927,000 0.06% of portfolio	5,692	Q4 2024 Reduced 2.06%
TAK Takeda Pharmaceutical CO LTD	$44.8B	$149,000 0.01% of portfolio	11,281	Q4 2024 Reduced 9.61%
NBIX Neurocrine Biosciences Inc	$11.4B	$91,000 0.01% of portfolio	669	Q4 2024 Added 1.21%
HLN Haleon PLC	$47B	$67,000 0.0% of portfolio	7,095	Q4 2024 Reduced 11.3%
LNTH Lantheus Holdings, Inc.	$6.45B	$65,000 0.0% of portfolio	729	Q4 2024 Added 65.68%
AMPH Amphastar Pharmaceuticals, Inc.	$1.39B	$39,000 0.0% of portfolio	1,063	Q4 2024 Added 10.84%
PRGO Perrigo CO PLC	$3.9B	$23,000 0.0% of portfolio	910	Q4 2024 Reduced 13.99%
VTRS Viatris Inc	$11.2B	$6,000 0.0% of portfolio	494	Q4 2024 Reduced 80.74%
EOLS Evolus, Inc.	$818M	$1,000 0.0% of portfolio	154	Q1 2023 New
ORGO Organogenesis Holdings Inc.	$813M	$0 0.0% of portfolio	0	Q4 2024 New
PCRX Pacira Bio Sciences, Inc.	$1.1B	$0 0.0% of portfolio	0	Q4 2024 New
PAHC Phibro Animal Health Corp	$462M	$0 0.0% of portfolio	0	Q4 2024 New
PBH Prestige Consumer Healthcare Inc.	$4.22B	$0 0.0% of portfolio	1	Q3 2024 Reduced 94.44%
PROC Procaps Group, S.A.	$120M	$0 0.0% of portfolio	0	Q4 2024 New
PRPH Pro Phase Labs, Inc.	$7.21M	$0 0.0% of portfolio	0	Q4 2024 New
RDHL Red Hill Biopharma Ltd.	$213M	$0 0.0% of portfolio	0	Q4 2024 New
RGC Regencell Bioscience Holdings LTD	$59.9M	$0 0.0% of portfolio	0	Q4 2024 New
RMTI Rockwell Medical, Inc.	$17.8M	$0 0.0% of portfolio	0	Q4 2024 New
SCYX Scynexis Inc	$33.6M	$0 0.0% of portfolio	0	Q4 2024 New
SIGA Siga Technologies Inc	$401M	$0 0.0% of portfolio	0	Q4 2024 New
SSIC Silver Spike Investment Corp.	$0	$0 0.0% of portfolio	0	Q4 2024 New
SBFMW Sunshine Biopharma Inc Wt Exp	$0	$0 0.0% of portfolio	0	Q4 2024 New
SUPN Supernus Pharmaceuticals, Inc.	$1.72B	$0 0.0% of portfolio	24	Q4 2024 Added 9.09%
TEVA Teva Pharmaceutical Industries LTD	$18.3B	$0 0.0% of portfolio	0	Q4 2024 New
TLRY Tilray Brands, Inc.	$452M	$0 0.0% of portfolio	88	Q4 2023 Reduced 91.91%
ZOM Zomedica Corp.	$108M	$0 0.0% of portfolio	0	Q4 2024 New
AKAN Akanda Corp.	$52.1M	$0 0.0% of portfolio	0	Q4 2024 New
ALKS Alkermes Plc.	$5.64B	$0 0.0% of portfolio	0	Q4 2024 New
TKNO Alpha Teknova, Inc.	$183M	$0 0.0% of portfolio	0	Q4 2024 New
ALVO Alvotech	$2.82B	$0 0.0% of portfolio	0	Q4 2024 New
AMRX Amneal Pharmaceuticals, Inc.	$1.31B	$0 0.0% of portfolio	0	Q4 2024 New
ANIP Ani Pharmaceuticals Inc	$1.08B	$0 0.0% of portfolio	0	Q4 2024 New
AQST Aquestive Therapeutics, Inc.	$149M	$0 0.0% of portfolio	0	Q4 2024 New
ASRT Assertio Holdings, Inc.	$37.6M	$0 0.0% of portfolio	0	Q4 2024 New
ATNX Athenex, Inc.	$1.57M	$0 0.0% of portfolio	0	Q4 2024 New
AYTU Aytu Biopharma, Inc	$80.5M	$0 0.0% of portfolio	0	Q4 2024 New
BHC Bausch Health Companies Inc.	$2.69B	$0 0.0% of portfolio	0	Q4 2024 Sold Out
CRDL Cardiol Therapeutics Inc.	$71.2M	$0 0.0% of portfolio	0	Q4 2024 New
CPHI China Pharma Holdings, Inc.	$10.6M	$0 0.0% of portfolio	0	Q4 2024 New
COLL Collegium Pharmaceutical, Inc	$991M	$0 0.0% of portfolio	0	Q4 2024 New
CRON Cronos Group Inc.	$775M	$0 0.0% of portfolio	0	Q4 2024 New
CPIX Cumberland Pharmaceuticals Inc	$71.3M	$0 0.0% of portfolio	0	Q4 2024 New
CYTH Cyclo Therapeutics, Inc.	$6.41M	$0 0.0% of portfolio	0	Q4 2024 New
RDY Dr Reddys Laboratories LTD	$2.12B	$0 0.0% of portfolio	0	Q4 2024 New
DVAX Dynavax Technologies Corp	$1.74B	$0 0.0% of portfolio	0	Q4 2024 New
ELAN Elanco Animal Health Inc	$5.3B	$0 0.0% of portfolio	0	Q4 2024 New
EMBC Embecta Corp.	$781M	$0 0.0% of portfolio	33	Q4 2023 Reduced 5.71%
EBS Emergent Bio Solutions Inc.	$373M	$0 0.0% of portfolio	0	Q4 2024 New
ESPR Esperion Therapeutics, Inc.	$113M	$0 0.0% of portfolio	0	Q4 2024 New
EVO Evotec Se	$1.49B	$0 0.0% of portfolio	0	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.